Pfizer

For more than 20 years, Pfizer has been advancing understanding of the immune system and innovating in rheumatology, gastroenterology, and medical dermatology. As a global healthcare leader, Pfizer focuses its efforts on six major therapeutic areas: vaccines, oncology, rare diseases, inflammation and immunology, internal medicine, and anti-infectives. In France, Pfizer relies on open and collaborative R&D, in partnership with leading institutions such as INSERM, the Pasteur Institute, the Brain Institute, and Unicancer, as well as numerous innovative biotechnology companies. The group is investing more than €1 billion between now and 2026 to strengthen research, development, and drug production in France.